| Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients B Testoni, F Lebossé, C Scholtes, F Berby, C Miaglia, M Subic, A Loglio, ... Journal of hepatology 70 (4), 615-625, 2019 | 274 | 2019 |
| Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins V Icard, O Diaz, C Scholtes, L Perrin-Cocon, C Ramière, ... PloS one 4 (1), e4233, 2009 | 150 | 2009 |
| Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation C Charre, C Ginevra, M Sabatier, H Regue, G Destras, S Brun, G Burfin, ... Virus evolution 6 (2), veaa075, 2020 | 143 | 2020 |
| Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity Y Debing, C Ramière, K Dallmeier, G Piorkowski, MA Trabaud, F Lebossé, ... Journal of hepatology 65 (3), 499-508, 2016 | 139 | 2016 |
| Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta D Roulot, S Brichler, R Layese, Z BenAbdesselam, F Zoulim, V Thibault, ... Journal of Hepatology 73 (5), 1046-1062, 2020 | 120 | 2020 |
| Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRα C Ramiere, C Scholtes, O Diaz, V Icard, L Perrin-Cocon, MA Trabaud, ... Journal of virology 82 (21), 10832-10840, 2008 | 107 | 2008 |
| Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR C Scholtes, O Diaz, V Icard, A Kaul, R Bartenschlager, V Lotteau, P André Journal of hepatology 48 (2), 192-199, 2008 | 82 | 2008 |
| Direct‐acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C V Virlogeux, P Pradat, K Hartig‐Lavie, F Bailly, M Maynard, G Ouziel, ... Liver International 37 (8), 1122-1127, 2017 | 76 | 2017 |
| Hepatitis C virus spread from HIV-positive to HIV-negative men who have sex with men C Charre, L Cotte, R Kramer, P Miailhes, M Godinot, J Koffi, C Scholtes, ... PloS one 13 (1), e0190340, 2018 | 72 | 2018 |
| Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis A Loglio, P Ferenci, SCU Renteria, CYL Tham, C Scholtes, H Holzmann, ... Journal of hepatology 76 (2), 464-469, 2022 | 60 | 2022 |
| The metabolic sensors FXRα, PGC‐1 α, and SIRT1 cooperatively regulate hepatitis B virus transcription C Curtil, LS Enache, P Radreau, AG Dron, C Scholtès, A Deloire, ... The FASEB Journal 28 (3), 1454-1463, 2014 | 58 | 2014 |
| High plasma level of nucleocapsid‐free envelope glycoprotein‐positive lipoproteins in hepatitis C patients C Scholtes, C Ramiere, D Rainteau, L Perrin‐Cocon, C Wolf, L Humbert, ... Hepatology 56 (1), 39-48, 2012 | 56 | 2012 |
| Non-invasive biomarkers for chronic hepatitis B virus infection management C Charre, M Levrero, F Zoulim, C Scholtès Antiviral Research 169, 104553, 2019 | 54 | 2019 |
| Hepatitis A outbreak in HIV-infected MSM and in PrEP-using MSM despite a high level of immunity, Lyon, France, January to June 2017 C Charre, C Ramière, AM Roque-Afonso, C Chidiac, F Zoulim, M Godinot, ... Eurosurveillance 22 (48), 17-00742, 2017 | 47 | 2017 |
| Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension E Degasperi, MP Anolli, SCU Renteria, D Sambarino, M Borghi, ... Journal of hepatology 77 (6), 1525-1531, 2022 | 43 | 2022 |
| Naturally occurring resistance-associated variants of hepatitis C virus protease inhibitors in poor responders to pegylated interferon-ribavirin S Larrat, S Vallet, S David-Tchouda, A Caporossi, J Margier, C Ramière, ... Journal of Clinical Microbiology 53 (7), 2195-2202, 2015 | 41 | 2015 |
| Standardized one-step real-time reverse transcription-PCR assay for universal detection and quantification of hepatitis delta virus from clinical samples in the presence of a … C Scholtes, V Icard, M Amiri, P Chevallier-Queyron, MA Trabaud, ... Journal of Clinical Microbiology 50 (6), 2126-2128, 2012 | 39 | 2012 |
| Hepatitis E in liver transplant recipients in the Rhone-Alpes region in France C Buffaz, C Scholtes, AG Dron, P Chevallier-Queyron, J Ritter, P Andre, ... European journal of clinical microbiology & infectious diseases 33, 1037-1043, 2014 | 37 | 2014 |
| Preliminary evidence for hepatitis delta virus exposure in patients who are apparently not infected with hepatitis B virus I Chemin, FH Pujol, C Scholtès, CL Loureiro, F Amirache, M Levrero, ... Hepatology 73 (2), 861-864, 2021 | 35 | 2021 |
| Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic … NP Komas, S Ghosh, M Abdou-Chekaraou, P Pradat, N Al Hawajri, ... PLOS Neglected Tropical Diseases 12 (4), e0006377, 2018 | 32 | 2018 |
